AmeriFlex Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
AmeriFlex Group's BIO Position: Q3 2026 in Review
AmeriFlex Group sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2026, closing a stake of 2 shares — an estimated $587 sold.
AmeriFlex Group first reported a position in BIO in Q4 2024 and held it in 5 quarters. The position peaked at $10.7K in Q3 2025. 380 funds tracked by Wall St. Rank hold BIO as of Q3 2026.
- AmeriFlex Group reported no remaining Bio-Rad Laboratories Class A position as of Q3 2026 after selling out during the quarter.
- AmeriFlex Group sold 2 Bio-Rad Laboratories Class A shares in Q3 2026, an estimated $587.
- AmeriFlex Group first reported a position in Bio-Rad Laboratories Class A in Q4 2024 and held it in 5 quarters.
- AmeriFlex Group's Bio-Rad Laboratories Class A position peaked at $10.7K in Q3 2025.
- 380 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.
Based on AmeriFlex Group's 13F filing for Q3 2026, filed 13 Nov 2026.